This topic contains a solution. Click here to go to the answer

Author Question: While a patient is receiving an aminoglycoside medication by intramuscular injection, the provider ... (Read 91 times)

Bob-Dole

  • Hero Member
  • *****
  • Posts: 547
While a patient is receiving an aminoglycoside medication by intramuscular injection, the provider should instruct the patient to expect:
 
  a. discomfort to the injection site, which can be treated with warm moist heat.
  b. development of localized infection, which can be treated with an occlusive dressing.
  c. discomfort to the injection site, which can best be relieved with narcotic analgesics.
  d. development of localized bleeding, which may require the application of an occlusive dressing.

Question 2

A patient who was recently hospitalized and treated with gentamicin tells the primary care NP, My kidney function test was abnormal and they stopped the medication. The patient is worried about long-term effects. The NP should:
 
  a. monitor renal function for several months.
  b. reassure the patient that complete recovery should occur.
  c. refer the patient to a nephrologist for follow-up evaluation.
  d. monitor serum electrolytes and serum creatinine and BUN.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Hikerman221

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A
The administration of aminoglycosides by intramuscular injection may cause discomfort to the injection site, which can be treated with warm moist heat and mild analgesics.

Answer to Question 2

B
Recovery of renal function occurs if the drug is stopped at the first sign of renal impairment. It is necessary to monitor blood values during therapy to ensure effectiveness and prevent toxicity.



Bob-Dole

  • Hero Member
  • *****
  • Posts: 547
Both answers were spot on, thank you once again




 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

For a complete list of videos, visit our video library